Mid-Atlantic Division
CHTN_CRC3 - Colorectal Carcinoma Progression
TMA Map
Code Key
| Code | Tissue type | # of cases* |
|---|---|---|
| Bnc | normal non-neoplastic colonic mucosa from non-cancer cases | 7 |
| Bc | normal non-neoplastic colonic mucosa from cancer cases | 7 |
| Bi | inflamed and/or regenerative non-neoplastic mucosa (ulcerative colitis) | 7 |
| AS | adenomas, < 2 cm in maximum dimension | 7 |
| AL | adenomas, > 2 cm in maximum dimension | 7 |
| CE | primary invasive adenocarcinoma, pathologic stage T1 or T2 | 7 |
| CL | primary invasive adenocarcinoma, pathologic stage T3 or T4 | 7 |
| LN | colorectal adenocarcinoma metastatic to lymph nodes, same cases as CL primary cancers | 7 |
| M | colorectal adenocarcinoma metastatic to distant sites | 7 |
| Con1 | Spleen (control tissue) | |
| Con2 | Kidney (control tissue) | |
| Con3 | Placenta (control tissue) | |
| Con4 | Liver (control tissue) | |
*This number represents the number of cases selected in the original design of the TMA. Due to the non-uniformity inherent to tissue samples and histologic techniques, not all cases will be represented in all of the TMA sections. In quality assurance assessment of the TMA sections, a minimum of10 cases each of non-neoplastic mucosa, adenoma, primary carcinoma, and metastatic tumor must be present in at least one tissue spot. | ||